Exponent, Inc. (EXPO): Officer received 6,008 units
John Pye, Officer at Exponent, Inc., reported a grant / award of 6,008 units.
- 6,008
- Derivative units
- Traded
- Apr 6, 2026
- Filed
- Apr 9, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Feb 9, 2026Federal contract · $58K obligatedDepartment of Justice awarded EXPONENT INC: $58K obligated to date
- Feb 9, 2026Federal contract · $99K obligatedDepartment of Justice awarded EXPONENT INC: $99K obligated to date
- Feb 9, 2026Federal contract · $99K obligatedDepartment of Justice awarded EXPONENT INC: $99K obligated to date
- Feb 10, 2026Insider · 1 personInsiders: 2 sales (~$304K)
- Feb 17, 2026Insider · 1 personInsiders: 2 sales (~$263K)
- Mar 4, 2026Federal contract · $327K obligatedDepartment of Justice awarded EXPONENT INC: $327K obligated to date
- Mar 16, 2026Insider · 1 personInsiders: 2 sales (~$264K)
- Apr 6, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 6, 2026, Exponent, Inc.’s (the “Company”) board of directors (the “Board”) appointed Dr. Pye as its President, effective as of May 1, 2026. Dr. Pye, age 55, joined the Company in 1999.”
What came next
- Apr 15, 2026Insider · 1 personInsiders: 2 sales (~$265K)
- Apr 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- May 13, 2026Insider · 2 peopleInsiders: 2 sales (~$278K)
- May 15, 2026Insider · 1 personInsiders: 2 sales (~$227K)
- May 19, 2026InsiderOfficer sold ~$98K of EXPO shares in the open market
- May 26, 2026InsiderOfficer sold ~$115K of EXPO shares in the open market
- Jun 15, 2026Insider · 1 personInsiders: 2 sales (~$235K)
- Jul 1, 2026Federal contract · $61K obligatedDepartment of Justice awarded EXPONENT INC: $61K obligated to date
- Jul 15, 2026InsiderCEO sold ~$109K of EXPO shares in the open market
- Jul 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Exponent, Inc.
For Exponent, Inc., OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its EXPO page.
Other recent filings by John Pye, VP Global Offices & Innovation
- SEC Form 4 at Exponent, Inc. (EXPO)Feb 12, 2026
- SEC Form 4 at Exponent, Inc. (EXPO)Feb 12, 2026
- SEC Form 4 at Exponent, Inc. (EXPO)May 23, 2025
- SEC Form 4 at Exponent, Inc. (EXPO)May 23, 2025
The full history of John Pye, VP Global Offices & Innovation is on the profile page.
How this filing works
Explore the data
Common questions
Which Exponent, Inc. (EXPO) insider traded, and how much?
John Pye, Officer at Exponent, Inc., reported a grant / award of 6,008 units. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Apr 6, 2026. Filed: Apr 9, 2026. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Exponent, Inc. recently?
For Exponent, Inc., OQRO holds 2 insider filings (SEC Form 4 or Form 144), 1 fund holdings report (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the EXPO page.
Does this mean EXPO stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Exponent, Inc.
- SEC Form 13F-HRNov 16, 2026
- SEC Form 4Nov 4, 2026
- SEC Form 144Nov 3, 2026
- USAspending.gov award recordOct 7, 2026
- USAspending.gov award recordOct 7, 2026
- SEC Form 4Aug 19, 2026
Everything OQRO holds on this company is on its EXPO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
